Currently submitted to: JMIR Research Protocols
Date Submitted: Mar 23, 2026
Open Peer Review Period: Mar 25, 2026 - May 20, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Artificial Intelligence (AI) in Psychiatry for Improving Continuity of Patient Care; Systematic Review Protocol
ABSTRACT
Background:
Continuity of care—defined as coherent, connected services across providers—is critical for psychiatric patients with chronic conditions but challenged by fragmentation at primary-secondary-community interfaces, poor data interoperability, and transitions. AI/ML tools (e.g., predictive algorithms for relapse, NLP for data synthesis, chatbots for engagement, digital phenotyping) promise to enhance informational, relational, and managerial continuity by automating monitoring, triaging high-risk cases, and bridging care gaps. Despite growing applications, no rigorous synthesis evaluates their efficacy, typologies, patient experiences, or implementation factors in psychiatry.
Objective:
This PROSPERO-registered systematic review will assess AI/ML interventions' effectiveness vs. standard care for continuity in adult psychiatric care; categorize AI architectures; synthesize patient-reported outcomes (PROs); and identify ethical/implementation barriers/facilitators.
Methods:
Guided by Cochrane Handbook and PRISMA-P, we will search MEDLINE, Embase, Cochrane CENTRAL, CINAHL, PsycINFO (2016–2025), trial registries (ClinicalTrials.gov, ICTRP), and references. PICO: P adults ≥21 years with primary psychiatric diagnoses; I any AI/ML for post-encounter continuity (prediction, NLP, chatbots); C standard care (case management, ACT, non-AI reminders); O readmissions, follow-up latency, adherence, attrition, PROs/satisfaction; designs: RCTs, cohorts, qualitative/mixed-methods (English, peer-reviewed). Dual independent screening/extraction in Covidence (pilot-tested, ≥80% agreement); data extraction for study characteristics, PICO details, effect sizes (RR/HR/means/SD); author contact (3 attempts) for missing data. Risk of bias: RoB 2.0 (RCTs), ROBINS-I (NRSIs), CASP (qualitative). Synthesis: random-effects meta-analysis (RevMan) if homogeneous (I²<50%); narrative/thematic otherwise; GRADE for certainty; funnel plots/Egger's for publication bias (≥10 studies); sensitivity analyses for imputation/heterogeneity.
Results:
We expect AI/ML to reduce readmissions (RR 0.7–0.9) and improve adherence via proactive tools, with barriers like privacy/clinician resistance and facilitators like workflow integration.
Conclusions:
Findings will map multi-level (patient/community/system) applications, guide equitable AI deployment in resource-constrained systems like Singapore's, and inform policy for person-centered psychiatric care. Clinical Trial: PROSPERO CRD420251245352
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.